BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15867362)

  • 1. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells.
    Pan J; She M; Xu ZX; Sun L; Yeung SC
    Cancer Res; 2005 May; 65(9):3671-81. PubMed ID: 15867362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase.
    Lu HR; Zhu H; Huang M; Chen Y; Cai YJ; Miao ZH; Zhang JS; Ding J
    Mol Pharmacol; 2005 Oct; 68(4):983-94. PubMed ID: 16024664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells.
    Jang SH; Lim JW; Morio T; Kim H
    Free Radic Biol Med; 2012 Feb; 52(3):607-615. PubMed ID: 22178412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.
    Sebti SM; Hamilton AD
    Oncogene; 2000 Dec; 19(56):6584-93. PubMed ID: 11426643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors.
    Du W; Prendergast GC
    Cancer Res; 1999 Nov; 59(21):5492-6. PubMed ID: 10554025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of phosphatidylinositol 3-kinase-related protein kinases in hyperphosphorylation of replication protein A2 in response to replication-mediated DNA double-strand breaks.
    Sakasai R; Shinohe K; Ichijima Y; Okita N; Shibata A; Asahina K; Teraoka H
    Genes Cells; 2006 Mar; 11(3):237-46. PubMed ID: 16483312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter.
    Delarue FL; Adnane J; Joshi B; Blaskovich MA; Wang DA; Hawker J; Bizouarn F; Ohkanda J; Zhu K; Hamilton AD; Chellappan S; Sebti SM
    Oncogene; 2007 Feb; 26(5):633-40. PubMed ID: 16909123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase.
    Wang H; Guan J; Wang H; Perrault AR; Wang Y; Iliakis G
    Cancer Res; 2001 Dec; 61(23):8554-63. PubMed ID: 11731442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
    Wang HC; Chou WC; Shieh SY; Shen CY
    Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase.
    Tanaka T; Halicka HD; Traganos F; Seiter K; Darzynkiewicz Z
    Cell Cycle; 2007 Feb; 6(3):371-6. PubMed ID: 17297310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of nitric oxide in farnesyltransferase inhibitor-mediated apoptosis in chronic myeloid leukemia cells.
    Selleri C; Maciejewski JP; Montuori N; Ricci P; Visconte V; Serio B; Luciano L; Rotoli B
    Blood; 2003 Aug; 102(4):1490-8. PubMed ID: 12714496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of ataxia telangiectasia mutated gene can increase intracellular reactive oxygen species levels and alter radiation-induced cell death pathways in human glioma cells.
    Wang SC; Wu CC; Wei YY; Hong JH; Chiang CS
    Int J Radiat Biol; 2011 Apr; 87(4):432-42. PubMed ID: 21204616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.
    Du W; Lebowitz PF; Prendergast GC
    Mol Cell Biol; 1999 Mar; 19(3):1831-40. PubMed ID: 10022870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors.
    Liu Ax; Du W; Liu JP; Jessell TM; Prendergast GC
    Mol Cell Biol; 2000 Aug; 20(16):6105-13. PubMed ID: 10913192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of DNA-PK and ATM in radiation- and heat-induced DNA damage recognition and apoptotic cell death.
    Tomita M
    J Radiat Res; 2010; 51(5):493-501. PubMed ID: 20814172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Ras targets of farnesyltransferase inhibitors: focus on Rho.
    Lebowitz PF; Prendergast GC
    Oncogene; 1998 Sep; 17(11 Reviews):1439-45. PubMed ID: 9779989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage caused by metal nanoparticles: involvement of oxidative stress and activation of ATM.
    Wan R; Mo Y; Feng L; Chien S; Tollerud DJ; Zhang Q
    Chem Res Toxicol; 2012 Jul; 25(7):1402-11. PubMed ID: 22559321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic response to farnesyltransferase inhibitors: proapoptotic targets of RhoB.
    Kamasani U; Liu AX; Prendergast GC
    Cancer Biol Ther; 2003; 2(3):273-80. PubMed ID: 12878865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ATM and histone H2AX phosphorylation induced by mitoxantrone but not by topotecan is prevented by the antioxidant N-acetyl-L-cysteine.
    Huang X; Kurose A; Tanaka T; Traganos F; Dai W; Darzynkiewicz Z
    Cancer Biol Ther; 2006 Aug; 5(8):959-64. PubMed ID: 16760673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.